🎉 Gate xStocks Trading is Now Live! Spot, Futures, and Alpha Zone – All Open!
📝 Share your trading experience or screenshots on Gate Square to unlock $1,000 rewards!
🎁 5 top Square creators * $100 Futures Voucher
🎉 Share your post on X – Top 10 posts by views * extra $50
How to Participate:
1️⃣ Follow Gate_Square
2️⃣ Make an original post (at least 20 words) with #Gate xStocks Trading Share#
3️⃣ If you share on Twitter, submit post link here: https://www.gate.com/questionnaire/6854
Note: You may submit the form multiple times. More posts, higher chances to win!
📅 July 3, 7:00 – July 9,
The identification of the executive director of Linghang Medical Biotechnology is exposed: Two founders of Conflux hold concurrent positions.
According to Gate News bot, the latest public information shows that Long Fan and Wu Ming, the two founders of Conflux, also serve as executive directors of the Hong Kong-listed company Leading Pharmaceutical Biotechnology.
Navi Pharmaceutical Biotechnology currently has a total market value of approximately HKD 371 million (equivalent to USD 47.26 million). Meanwhile, the total market value of Conflux (CFX) token has reached USD 393 million, ranking 138th in the cryptocurrency market capitalization leaderboard.
Earlier reports indicated that Pioneer Pharma Biotechnology (00399) announced that the company will sign a memorandum of understanding with Northwestern Foundation (the seller) and Conflux on June 30, 2025, with the intention of acquiring all the shares of the target company. This potential acquisition aims to assist the company in entering the digital innovation field, which will not only diversify the group’s business but is also expected to bring new profit growth points for the group.